As
filed with the Securities and Exchange Commission on March 26,
2010.
Registration No.
333-56171
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
____________________
POST-EFFECTIVE
AMENDMENT NO. 2 TO
FORM
S-8
REGISTRATION
STATEMENT
____________________
QUADRAMED
CORPORATION
(Exact
name of Registrant as specified in its charter)
Delaware
(State
or other jurisdiction of
incorporation
or organization)
|
|
52-1992861
(I.R.S.
Employer
Identification
Number)
|
12110
Sunset Hills Road
Reston,
Virginia 21090
(Address
and telephone number of Registrant’s principal executive offices)
QUADRAMED
CORPORATION 1996 STOCK INCENTIVE PLAN
MEDICUS
SYSTEMS CORPORATION 1994 DIRECTORS’ STOCK OPTION PLAN
MEDICUS
SYSTEMS CORPORATION 1995 RCM STOCK OPTION PLAN
MEDICUS
SYSTEMS CORPORATION 1996 CEO REPLACEMENT STOCK OPTION PLAN
MEDICUS
SYSTEMS CORPORATION 1996 CEO SPECIAL STOCK OPTION CERTIFICATE
MEDICUS
SYSTEMS CORPORATION 1997 EMPLOYEE STOCK OPTION AND RESTRICTED STOCK
PLAN
MEDICUS
SYSTEMS CORPORATION (1989/1991/1993/1993 PERFORMANCE, AND 1994) STOCK OPTION AND
RESTRICTED STOCK PLAN
MEDICUS
SYSTEMS CORPORATION 1997 DIRECTORS’ STOCK OPTION PLAN
(Full
title of the plans)
Chris
Adams
Secretary
QuadraMed
Corporation
12110
Sunset Hills Road
Reston,
Virginia 20190
(703)
709-2300
(Name,
address and telephone number of agent for service)
Copies
to:
Michael
J. Kennedy
Michael
S. Dorf
Shearman
& Sterling LLP
525
Market Street
San
Francisco, CA 94105
(415)
616-1100
Indicate
by check mark whether the registrant is a large accelerated filer, an
accelerated filer, a non-accelerated filer, or a smaller reporting
company. See the definitions of “large accelerated filer,”
“accelerated filer” and “smaller reporting company” in Rule 12b-2 of the
Exchange Act. (Check one):
|
Large accelerated
filer |
o |
Accelerated
filer |
o |
|
Non-accelerated
filer |
x |
Smaller reporting
company |
o |
EXPLANATORY
STATEMENT
QuadraMed Corporation (the
“Registrant”) is filing this Post-Effective Amendment No. 2 to Registration
Statement on Form S-8 filed on June 5, 1998 (File No. 333-56171), as amended by
Post-Effective Amendment No. 1 to the Registration Statement filed on
May 2, 2002 (the “Registration Statement”), to deregister certain shares of the
Registrant’s common stock, par value $0.01 per share (the “Common Stock”) that
were originally registered for issuance pursuant to the Medicus Systems
Corporation 1994 Directors’ Stock Option
Plan, the Medicus Systems Corporation 1995 RCM Stock Option Plan, the Medicus
Systems Corporation 1996 CEO Replacement Stock Option Plan, the Medicus Systems
Corporation 1996 CEO Special Stock Option Certificate, the Medicus Systems
Corporation 1997 Employee Stock Option and Restricted Stock Plan, the Medicus
Systems Corporation (1989/1991/1993/1993 Performance, and 1994) Stock Option and
Restricted Stock Plan and the Medicus Systems Corporation 1997 Directors’ Stock Option Plan
(collectively, the “Plans”). As set forth in Post-Effective Amendment
No. 1 to the Registration Statement, the Plans were subsequently rolled into the
QuadraMed Corporation 1996 Stock Incentive Plan (the “1996 Plan”).
A total of 555,695 shares issuable to
service providers of the Registrant pursuant to the Plans were registered under
the Registration Statement. A total of 222,458 shares became issuable
under the 1996 Plan when the Plans were rolled into the 1996 Plan. Subsequent to
this registration, on June 13, 2008, the Registrant announced the effectiveness
of the reverse split of its common stock in the ratio of
one-for-five.
In connection with the Registrant’s
filing of a Form 15 and suspension of duty to file reports under Sections 13 and
15(d) of the Securities Exchange Act of 1934, as amended, the Registration
Statement is hereby amended to deregister any shares of Common Stock remaining
unissued under the 1996 Plan.
PART
II
SIGNATURES
Pursuant to the requirements of the
U.S. Securities Act of 1933, as amended, the Registrant has duly caused this
Post-Effective Amendment No. 2 to the Registration Statement to be signed on its
behalf by the undersigned, thereunto duly authorized, in the city of San
Francisco, California, U.S.A. on March 26, 2010.
|
QuadraMed
Corporation |
|
|
|
|
|
|
|
|
|
|
|
|
By:
|
/s/ Chris Adams |
|
|
|
Name: |
Chris
Adams |
|
|
|
Title: |
Secretary |
|
|
|
|
|
|